The importance of several ovary-selective/specific genes, i.e. genes preferentially or exclusively expressed in the ovary, has been established. Indeed, null mutant female mice for the c-mos, growth and differentiation factor-9, ␣-inhibin, and zona pellucida-3 genes proved sterile. A loss of function mutation of the human FSH receptor gene established its critical role in ovarian function. These data support the hypothesis that genes expressed selectively or specifically in the ovary are probably essential for the normal functioning of this organ system. We have used the differential screening technique suppression subtractive hybridization to systematically isolate and clone genes that are expressed in an ovary-selective/specific manner. The resultant target complementary DNA (cDNA) library has been exhaustively screened to a point at which additional sequencing was increasingly unlikely (Յ4%) to yield additional previously unencountered cDNAs. In toto, 844 clones were sequenced and analyzed for homology to known genes using the Basic Local Alignment Tool (BLAST). Of those, 342 were determined to be independent (nonredundant). One hundred and fifty-nine independent clones proved identical to previously characterized genes, whereas an additional 100 independent clones proved significantly homologous (but not identical) to previously characterized genes. Yet 83 other independent clones did not display significant homology to previously characterized genes now listed in the publicly accessible nonredundant databases. As such, these latter genes were deemed novel. Of these 83 novel genes, a total of 36 displayed ovary-specific/selective expression, as determined by probing mouse multitissue Northern blots with 32 P-labeled/PCR-amplified cDNA inserts. Under these circumstances, the false positive rate was minimal, as only one novel clone was expressed at a higher level in nonovarian tissues relative to ovary. Of the 36 ovary-specific/ selective novel genes, 22 proved subject to hormonal regulation during a simulated estrous cycle. In this communication we focus on 2 such novel ovary-specific/hormonally-dependent genes, the full-length sequences of which were isolated using rapid amplification of 3Ј-cDNA ends technology. Taken together, the present study accomplished systematic identification of those genes that are restricted in their expression to the ovary. These ovary-selective genes may have significant implications for the understanding of ovarian function in molecular terms and for the development of innovative strategies for the promotion of fertility or its control. (Endocrinology 141: [2725][2726][2727][2728][2729][2730][2731][2732][2733][2734] 2000) 
acterized genes. Yet 83 other independent clones did not display significant homology to previously characterized genes now listed in the publicly accessible nonredundant databases. As such, these latter genes were deemed novel. Of these 83 novel genes, a total of 36 displayed ovary-specific/selective expression, as determined by probing mouse multitissue Northern blots with 32 P-labeled/PCR-amplified cDNA inserts. Under these circumstances, the false positive rate was minimal, as only one novel clone was expressed at a higher level in nonovarian tissues relative to ovary. Of the 36 ovary-specific/ selective novel genes, 22 proved subject to hormonal regulation during a simulated estrous cycle. In this communication we focus on 2 such novel ovary-specific/hormonally-dependent genes, the full-length sequences of which were isolated using rapid amplification of 3Ј-cDNA ends technology. Taken together, the present study accomplished systematic identification of those genes that are restricted in their expression to the ovary. These ovary-selective genes may have significant implications for the understanding of ovarian function in molecular terms and for the development of innovative strategies for the promotion of fertility or its control. (Endocrinology 141: [2725] [2726] [2727] [2728] [2729] [2730] [2731] [2732] [2733] [2734] 2000) A HIGHLY SYNCHRONIZED and exquisitely timed gene expression cascade controls the individual phases of the normal ovarian life cycle (1, 2) . The appropriate transition from one phase of the cycle to the next requires the timely expression of a specific gene(s) to ensure the correct continuation of this preprogrammed process. To date, a major research focus of students of ovarian function has been the analysis of mostly known genes.
In the last few years several genes have been determined to be expressed in an ovary-selective manner. Examples include members of the transforming growth factor-␤ superfamily, growth differentiation factor-9 (GDF-9) and ␣-inhibin (3, 4); c-mos, a 37-kDa cytoplasmic serine/threonine kinase (5); as well as the oocyte-derived zona pellucida (ZP) glycoproteins (ZP 1-3) (6) . Each of the preceding genes was isolated and studied on a case by case basis with regard to ovarian function.
The critical role that ovary-selective genes may play in ovarian physiology was subsequently established through the generation of null mutant mice. For example, the ovaries of null mutants for GDF-9 possessed normal numbers of primordial and primary follicles but were devoid of all downstream follicular stages (7). Female null mutants for c-mos proved infertile in that meiotically active oocytes failed to arrest at metaphase II and, in fact, attempted a third round of meiosis (8, 9) . Female null mutants for ZP-3 displayed markedly reduced (90%) ovulatory efficiency and consequent infertility, the complete absence of the ZP, and disorganization of the surrounding cumulus granulosa cells (10, 11) . These studies, through the generation of null mutants, established that the above-mentioned ovary-selective genes are critical to murine ovarian function.
Taken together, these and other studies serve to demonstrate that several genes, whether restricted in their expression to the ovary or preferentially expressed in the ovary, constitute critical molecular determinants of ovarian function. It was, therefore, the purpose of this communication to systematically isolate genes that are expressed in an ovaryselective/specific manner.
Materials and Methods

In vivo protocols
Female C57BL/6 mice, 19 days of age upon arrival, were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were initially quarantined for 3 days at the University of Utah Animal Resources Center. The latter adheres to the guidelines outlined by the Animal Welfare Act and by institutional animal care and use committee protocols. At 25 days of age, one group of mice (n ϭ 8) was killed by halothane-induced asphyxiation (Halocarbon, River Edge, NJ), thereby providing unstimulated ovarian material as well as nonovarian tissues. A second group of mice (n ϭ 37) was injected with 10 IU each of PMSG. Forty-eight hours after PMSG injection, a group of mice was killed (n ϭ 7) to secure ovaries at the preovulatory phase of a reproductive cycle. The remaining mice (n ϭ 30) were injected with 10 IU each of hCG. Subgroups (n ϭ 5/subgroup) of the latter were killed at 3, 6, 9, 12, 24, and 48 h post-hCG injection. Ovaries removed at 3, 6, 9, and 12 h post-hCG treatment encompass the interval preceding follicular rupture, whereas the 24 and 48 h post-hCG treatment groups encompass the luteal phase of the ovarian cycle.
RNA isolation
Total RNA was isolated from the following nonovarian tissues of immature 25-day-old female C57BL/6 mice: brain, heart, kidney, liver, spleen, and lung. Total RNA was also isolated from the ovaries of FIG. 1. SSH subtraction efficiency. Subtraction efficiency was determined by analyzing the amount of G3PDH present in both the unsubtracted starting cDNA and the subtracted target cDNA through the use of increasing number of PCR cycles (A). The signal intensity for G3PDH was determined for both the unsubtracted starting material as well as for the subtracted target material (B).
25-day-old female C57BL/6 mice undergoing superovulation as described above. The isolation of total RNA was performed using the RNAeasy Kit (QIAGEN, Santa Clara, CA) according to the manufacturer's directions. Polyadenylated [poly (A) ϩ ] RNA was subsequently isolated by the use of an oligo(deoxythymidine) magnetic sphere-based separation system (RNAatract, Promega Corp., Madison, WI).
Suppression subtractive hybridization (SSH)
SSH was performed with the PCR-Select Kit (CLONTECH Laboratories, Inc. San Diego, CA) according to the manufacturer's directions. Briefly, an equal amount of poly(A) ϩ RNA isolated from each of the nonovarian tissues was combined to generate a total of 1 g poly(A) ϩ RNA. This messenger RNA (mRNA) was used to generate the driver complementary DNA (cDNA) through the use of the SMART cDNA synthesis kit (CLONTECH Laboratories, Inc.) according to the manufacturer's instructions. Ovarian poly(A) ϩ RNA (1 g) isolated from mice undergoing the above-described superovulation protocol was used to construct the tester cDNA. Thirty primary and 12 secondary PCR cycles were used in amplifying the target (subtracted) ovary-selective cDNAs.
Cloning and sequencing of cDNAs
The PCR products generated by SSH were digested with RsaI to generate blunt ends and to remove the adapters previously ligated to both ends of the target cDNAs. These cDNAs were subsequently purified using QIAGEN's PCR purification system, ligated into the vector pCR-SCRIPT (Stratagene, San Diego, CA) and transformed into Escherichia coli strain XL-1Ј Blue (Stratagene). The individual cDNA inserts were isolated by PCR amplification using flanking T3 and T7 primer sites. The plasmid template used in the PCR reaction was obtained by the Wizard mini-prep kit (Promega Corp., Madison, WI) or by directly using the bacterial cultures lysed in ddH 2 0 at a dilution of 1:50. Purified/ PCR-amplified cDNAs were sequenced using T7 primers at the DNA sequencing core facility of the Huntsman Cancer Institute at the University of Utah Health Sciences Center using Perkin-Elmer Corp. ABI 377 automated sequencers. The sequence data obtained were analyzed for homology to previously characterized genes deposited in the National Center for Biotechnology Informatics (NCBI) database, which includes entries from GenBank, European Molecular Biology Laboratory (EMBL), and DNA Database of Japan (DDBJ) databases using the Basic Local Alignment Tool (BLAST) program.
Analysis of subtraction efficiency
An equal amount of cDNA from the (presubtraction) tester pool and final SSH-subtracted product were used as a template for the amplification of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (G3PDH). The forward (5Ј-TGAAGGTCGGTGTGAACGGATT-TGGC-3Ј) and reverse (5Ј-CATGTAGGCCATGAGGTCCACCAC-3Ј) G3PDH primers (CLONTECH Laboratories, Inc.) were used to amplify a 983-bp product within the following PCR parameters: denaturation, 94 C for 45 sec; annealing, 60 C for 45 sec; and extension, 72 C for 1 min and 30 sec. Samples were removed following the completion of 14, 18, 22, 26, and 30 cycles. The resultant amplicon was resolved on a 2% agarose gel stained with ethidium bromide.
Verification of ovary-selective expression (reverse Northern blot analysis)
Poly(A)
ϩ RNA from the previously described nonovarian and ovarian tissues was used to generate double stranded cDNA using the SMART cDNA synthesis system according to the manufacturer's directions (CLONTECH Laboratories, Inc.). The nonovarian and ovarian cDNAs generated were purified, quantified, separated on a 1% agarose gel, and blotted onto a Nylon membrane (MSI, Westborough, MA). The membranes were then probed with 32 P-labeled/PCR-amplified cDNA inserts according to the method of Sambrook et al. (12) . The blots were imaged, and band density was determined by a phosphorimager (BioRad Laboratories, Inc., Hercules, CA). Equal cDNA loading was confirmed by probing with a 32 P-labeled/PCR-amplified 983-bp G3PDH product.
Northern blot analysis
Total RNA (20 g) isolated from ovaries at different stages of the superovulation protocol was separated on denaturing 1% agarose-formaldehyde gels and transferred to nylon membranes according to the protocol of Sambrook et al. (12) . Before transfer, RNA quality and concentration were assessed by ethidium bromide staining and visualization under UV light. Nonovarian tissue blots (20 g total RNA) were purchased from Origene Technologies (Rockville, MD). Nylon membranes were prehybridized for 2-6 h at 42 C in 5 ϫ SSPE (sodium chloride-sodium phosphate-EDTA), 50% formamide, 5 ϫ Denhardt's solution, and 0.25% SDS. Probes were generated by radiolabeling individual PCR-amplified cDNA inserts with [ 32 P]deoxy-CTP using the random priming method (Amersham Pharmacia Biotech, Piscataway, NJ). The probes were denatured in a boiling water bath for 5 min before quenching with ice. Membranes were hybridized with the relevant probe overnight at 42 C in the same (above-mentioned) solution used for prehybridization. The membranes were washed in 2 ϫ SSC (standard saline citrate) and 0.1% SDS at room temperature three times for 5 min each time, followed by two washes in 0.125 ϫ SSC and 0.25% SDS for 15 min at 60 C. The blots were rinsed in 4 ϫ SSC and imaged through the use of a phosphorimager (Bio-Rad Laboratories, Inc.). The intensity of signals was quantified using Molecular Analyst software (Bio-Rad Laboratories, Inc.). Equivalent RNA loading was verified by probing the same (stripped) blots with radiolabeled PCR products of the housekeeping genes ␤-actin (for the ovarian blots) and G3PDH (for the nonovarian tissue blots).
Results and Discussion
The technique of SSH has been used in a variety of experimental settings for the analysis of differentially expressed genes (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . In this study SSH was employed to identify genes that are expressed in an ovary-selective manner. The efficiency of the SSH procedure, as assessed by depletion of the housekeeping gene G3PDH, was determined by PCR amplification over a graded increase in the number of cycles. In the subtracted (target) ovarian cDNA population, the amount of G3PDH was significantly reduced relative to that of the unsubtracted ovarian cDNA (Fig. 1A ). An additional 8 -12 PCR cycles were required for the subtracted (target) cDNA to achieve the same level of G3PDH amplification as in the unsubtracted ovarian cDNA. As PCR amplification is an exponential process, this differential in cycle number translates into a 256-to 4096-fold depletion of G3PDH cDNA in the subtracted ovarian material (Fig. 1B) .
After the cloning of the individual SSH-generated cDNA products into a plasmid vector and transformation of the latter into the appropriate bacterial host, 844 independent clones were isolated. The individual cDNA inserts were amplified using primers corresponding to plasmid sequences flanking the multiple cloning site. The individual PCR products were subsequently sequenced.
To establish an appropriate conclusion for the screening process of the subtracted ovary-selective library, the number of new sequences obtained was plotted against the total number of clones sequenced (Fig. 2) . Only 2 new clones were obtained upon sequencing the last batch of 50 clones. These results suggested that the screening of the subtracted ovarian cDNA library was all but complete and that few new sequences were probably derived by further screening.
Each sequenced clone was analyzed using the BLAST program and classified as known, homologous, or novel after its evaluation against entries within the publicly accessible nonredundant database of NCBI (Table 1) . Known genes were classified as such if the homology was complete (Ͼ98% identity) between the subtracted SSH-generated clone and the database match. The complete list of known genes isolated by SSH was deposited in the Ovarian Kaleidoscope Gene Database (http://ovary.stanford.edu). Clones were classified as homologous if they did not completely match (Ͻ98%) but exhibited an E probability value of Ͻ1 Ϫ5 relative to entries in the nonredundant database of NCBI. Novel clones were designated as such if no significant match (E probability value Ͼ1 Ϫ5 ) was obtained in the nonredundant database. Clones not matching entries within the nonredundant data- 3 . Verification of ovary-selective expression by reverse Northern blot analysis. PCR-amplified cDNA inserts from randomly picked clones were radiolabeled and used to probe blots containing cDNAs generated from nonovarian (driver) or ovarian (tester) mRNA. After the reverse Northern blot analysis, the cDNA inserts were sequenced to ascertain their identities. Equivalent cDNA loading of the blots was verified by probing with a radiolabeled G3PDH PCR product.
base were still designated as novel even if a complete sequence match was uncovered within the NCBI EST database. Such EST entries represent incomplete sequence information (ϳ300 -600 bp) of an uncharacterized gene and thus do not detract from the novelty designation. cDNAs possessing significant homology to genomic clones (i.e. cosmid, BAC, and PAC) were also classified as novel, as these entries are comprised of large uncharacterized DNA fragments from a variety of different species. Of the 844 clones analyzed, 342 were determined to be nonredundant (independent) sequences. It follows that different clones containing the same cDNA insert were sequenced multiple times. Of the 342 nonredundant genes sequenced, 159 corresponded to known genes, whereas 100 proved partially homologous to entries in the nonredundant NCBI database. Eighty-three clones were classified as novel, of which 66 shared homology with entries within the NCBI EST database.
The ovarian cDNAs isolated from the (subtracted/SSHgenerated) library that corresponded to known genes, included several that have previously been reported to be expressed, specifically or selectively, in the ovary (Table 2) . Examples include proteins encoded by genes involved in ovarian steroidogenesis [StAR, 3␤-hydroxysteroid dehydrogenase I (3␤HSD), 17␤HSD I, and aromatase) and in cell to cell communication (connexin-43) (24 -28) . Also noted were genes corresponding to secreted ovarian regulators (␣-inhibin, ␤B-inhibin, and GDF-9),and to the oocytic ZP-3 protein (3, 4, 6) . Interestingly, among the clones sequenced, the Mti10 retrotransposon was highly represented in the ovaryselective cDNA library (28 of 844 clones, or 3.3% of the total). The Mti10 retrotransposon, a mobile genetic element that relies on a RNA intermediate to move throughout the genome, belongs to the MaLR (mammalian apparent long terminal repeat-retrotransposons) family of transposons (29) . It has been estimated that most mammalian genomes contain between 40,000 -100,000 copies of family members of the MaLR retrotransposon, thereby accounting for a significant proportion of the genome (29) .
Although the utilization of SSH in the current study successfully yielded previously characterized ovary-specific genes, several expected genes were not present within the target cDNA library. For example, the oocyte-specific genes bone morphogenetic protein-15 (30) , factor in the germline-␣ (31), germ cell nuclear factor (32) , and c-mos (5) were not found within the subtracted ovarian library. Likewise, the granulosa cell-restricted FSH receptor cDNA (33) was not present within the final subtracted target ovarian cDNAs. The absence of these genes from the library may be due to an incomplete representation of the relevant mRNA in the tester cDNA pool that was used in the subtraction process. This hypothesis is supported by the observation that the genes in question could not be detected by PCR in the unsubtracted ovarian cDNAs used as the starting material for the SSH procedure (data not shown).
Both the tester and driver cDNA pools were generated by the use of the SMART (Switching Mechanism At 5Ј-end of RNA Transcript) cDNA synthesis kit (CLONTECH Laboratories, Inc.). This process relies on the addition of unique adapter oligonucleotides to the first strand cDNA. The unique adapters can then be used to prime the PCR amplification and the generation of double stranded cDNA. The advantage of this procedure is that it allows for the generation of large amounts of cDNA from limited quantities of RNA. Due to the utilization of PCR, however, some of the cDNAs may not be amplified as efficiently as others and may thus be lost from the SSH starting material. A similar inability to identify all of the expected known genes after a differential screening of retinal candidate genes was recently reported by others and ascribed to the incomplete representation of the total cDNA repertoire (34). A significant number of subtracted/SSH-generated cDNAs exhibited partial homology to entries in the nonredundant NCBI database ( Table 2) . Most of the cDNAs in this category probably represent mouse homologues of genes identified in other species (e.g. rat P450scc, rabbit 17␣-hydroxylase/17-20-lyase, etc.). A large proportion (n ϭ 104) of the clones isolated from the subtracted/SSH-generated cDNA library exhibited significant homology to rat P450scc, representing in all likelihood the mouse counterpart. Only the 5Ј-region of the mouse P450scc gene has previously been deposited in the NCBI database. The latter was mirrored by 29 clones isolated from the subtracted/SSH-generated cDNA library.
The degree of ovary-selective expression for 20 randomly chosen (SSH-derived) cDNAs was verified by reverse Northern analysis. Of the 20 clones analyzed, only 1 exhibited a higher level of expression in the nonovarian (driver) cDNA compared with the ovarian (tester) cDNA, demonstrating the low false positive rate associated with SSH in this experimental circumstance. Figure 3 depicts the ovary-selective expression of 3 cDNAs corresponding to known genes. Genes previously reported to be ovary-selective (GDF-9 and 3␤HSD) (4, 26) were confirmed as such. A member of the MT transposon family (Mti10) was also determined to be ovary selective by reverse Northern blot analysis. Ovary-selective expression of Mti10 was further supported by the observation that EST (expressed sequence tag)s corresponding to this transposable element have been isolated predominantly from unfertilized eggs and 2-cell embryo cDNA libraries. Confirmation of equivalent cDNA loading was accomplished by probing for the housekeeping gene G3PDH.
The novel SSH-generated cDNAs were subjected to further determination of ovarian and phase specificity by Northern blot analysis. Nylon membranes containing RNA from 12 different mouse tissues as well as RNA from indi- vidual phases (i.e. unstimulated, follicular, ovulatory, and luteal) of a simulated estrous cycle were probed with radiolabeled/PCR-amplified inserts corresponding to all 83 novel cDNA clones (Table 3) . From this analysis, 17 clones were determined to be ovary specific and phase specific. Only 4 ovary-specific clones were constitutively expressed throughout a simulated cycle. Fifteen of the 83 novel clones were classified as ovary selective, in that their ovarian expression proved highest, with limited expression in 1 or more of the nonovarian tissues. Of the 15 ovary-selective clones isolated, 5 were expressed in a phase-specific manner, with 10 being expressed constitutively. The expression of 46 of the novel cDNAs could not be detected by the Northern blot technique. This negative outcome may reflect the low level of sensitivity of the Northern blot methodology employed. Verification of ovary-selective or -specific expression of these 46 negative clones will require the use of a more sensitive methodology, such as RT-PCR, which is currently underway. Only 1 of the novel clones was expressed at a higher level in the nonovarian tissues relative to the ovarian RNA, demonstrating a low false positive rate (2.1%) for the SSH technique as used under this experimental circumstance.
From the group of novel genes determined to be ovary selective, two examples are presented in Fig. 4 . The expression of the two novel clones (M3-D2 and M7-A10) could not be detected in any of the nonovarian RNA samples. The presence of RNA on the membranes was verified by successfully reprobing for G3PDH transcripts.
The phase-specific expression pattern of clones M3-D2 and M7-A10 is shown in Fig. 5 . The expression of the M3-D2 gene increased approximately 4.5-fold relative to that in unstimulated ovaries 48 h after treatment with PMSG (Fig. 5, A and  C) . Increases of 10-and 9.6-fold (relative to unstimulated ovaries) were observed in the ovarian expression of the novel gene M3-D2 at 24 and 48 h after the injection of hCG to PMSG-primed mice (P Ͻ 0.05), respectively. Another novel gene (M7-A10), exhibited a 50% reduction in ovarian expression (relative to unstimulated ovaries) 6 h after the administration of hCG to PMSG-primed mice (P Ͻ 0.05; Fig. 5, B and  D) . However, 24 and 48 h post-hCG, the expression of M7-A10 was increased significantly (P Ͻ 0.05) relative to the control value (1.5-and 1.8-fold). The transcript sizes of the M3-D2 and M7-A10 genes, as calculated from the Northern blot analysis, were approximately 1.3 and 1.5 kbp, respectively. Equivalent RNA loading was verified by reprobing the same membrane for ␤-actin transcripts.
As SSH yields partial cDNA sequences, the full-length cDNA sequences of clones M3-D2 and M7-A10 were subsequently determined by rapid amplification of 3Ј-cDNA ends. The putative protein encoded by clones M3-D2 proved to be a 283-amino acid protein, the molecular mass of which was 29.9 kDa (Fig. 6A) . The latter proved highly acidic (theoret- ical pI of 3.9) due to the large number of glutamic acid residues (49 of a total of 283). Based on its restricted expression profile and highly acidic nature, we have termed this protein ovary-specific acidic protein (OSAP). According to the PSORT protein analysis tools (http://psort.nibb.ac.jp: 8000), OSAP does not possess a signal peptide, endoplasmic reticulum localization motifs, peroxisomal targeting sequences, or transmembrane-spanning domains. The PSORT cellular localization prediction algorithm suggested that OSAP may be directed to reside in the mitochondria. By using NCBI's BLASTp program, low but significant homology (E value of 10 Ϫ12 ) was observed between OSAP and the sea lamprey neurofilament protein (NF-180). The acidic regions of neurofilament proteins from other species were also found to possess limited but significant homology to OSAP (data not shown).
The open reading frame, derived from the full-length cDNA sequence of M7-A10 encodes a 235-amino acid protein, the molecular mass of which proved to be 26.8 kDa (Fig.  6B) . PSORT analysis suggested that the M7-A10 protein lacks a signal peptide, ER localization motifs, peroxisomal targeting sequences, or transmembrane-spanning domains. The PSORT cellular localization prediction algorithm suggested that M7-A10 localizes to the cytoplasm. By using NCBI's BLASTp program, M7-A10 was found to possess significant homology only at the amino acid level to 2 yeast proteins, termed MOB1 and MOB2 (Fig. 7) . MOB1 (Mps One Binder) was originally identified via a yeast two-hybrid system as a binding partner for the yeast protein kinase MPS1 (35) . MPS1, in turn, is necessary for proper mitotic checkpoint control and spindle pole body duplication (36) . Conditional (temperature-sensitive) alleles for the yeast MOB1 gene gave rise to a late nuclear division arrest at the restrictive temperature (35) . Another MPS1 binding protein was subsequently cloned and named MOB2 (35) . The MOB2 protein also exhibited significant homology to the ovary-specific clone M7-A10. Based on the homology among M7-A10, MOB1, and MOB2, we propose that this new putative protein be named mammalian MOB homolog.
The mitotic defects associated with MOB1 and MOB2 yeast mutants may be related to their interaction with another protein, termed MPS1. MPS1 encodes an essential dual specificity kinase whose activity is required for both spindle body duplication, a process necessary for proper chromosomal segregation and the maintenance of the correct complement of chromosomes (36 -38) . Additionally, MPS1 is responsible for arrest at a mitotic checkpoint. Mitotic arrest of cells is an important process that allows for correction of spindle body defects and repair of DNA damage (39) . Taken together, these yeast studies suggest a role for the ovary-specific mammalian MOB homolog in the maintenance of chromosomal integrity in the ovary, possibly during meiosis. 
